Open AccessShould a protease inhibitor be standard of care for HIV postexposure prophylaxis?
Author(s) -
John McAllister,
Andrew Carr
Publication year - 2011
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e32834168bd
Subject(s) - tolerability , lopinavir , ritonavir , adverse effect , regimen , medicine , protease inhibitor (pharmacology) , toxicity , virology , surgery , pharmacology , viral load , human immunodeficiency virus (hiv) , antiretroviral therapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom